Navigating a ‘Revolutionary Era’ of Targeted Therapy in Pancreatic Cancer
Prior to his presentation on immunotherapy in pancreatic cancer treatment at the 15th Annual Ruesch Symposium, Gregory L. Beatty, MD, PhD, stated his hope that this type of treatment will start to affect the 5-year survival for patients with metastatic …